Literature DB >> 11112758

Drug treatment of multiple sclerosis

.   

Abstract

Year:  2000        PMID: 11112758      PMCID: PMC1071194          DOI: 10.1136/ewjm.173.6.398

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  26 in total

1.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 2.  New insights into the immunogenetics of multiple sclerosis.

Authors:  J R Oksenberg; S L Hauser
Journal:  Curr Opin Neurol       Date:  1997-06       Impact factor: 5.710

Review 3.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

Authors:  R Hohlfeld
Journal:  Brain       Date:  1997-05       Impact factor: 13.501

4.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

5.  Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Authors:  J H Simon; L D Jacobs; M Campion; K Wende; N Simonian; D L Cookfair; R A Rudick; R M Herndon; J R Richert; A M Salazar; J J Alam; J S Fischer; D E Goodkin; C V Granger; M Lajaunie; A L Martens-Davidson; M Meyer; J Sheeder; K Choi; A L Scherzinger; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; R H Whitham
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

6.  Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.

Authors:  D Barnes; R A Hughes; R W Morris; O Wade-Jones; P Brown; T Britton; D A Francis; G D Perkin; P Rudge; M Swash; H Katifi; S Farmer; J Frankel
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

7.  Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

Review 8.  The natural history of multiple sclerosis.

Authors:  B G Weinshenker
Journal:  Neurol Clin       Date:  1995-02       Impact factor: 3.806

9.  Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Authors:  L D Jacobs; D L Cookfair; R A Rudick; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; C V Granger; J H Simon; J J Alam; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; M E Coats; S L Cohan; D S Dougherty; R P Kinkel; M K Mass; F E Munschauer; R L Priore; P M Pullicino; B J Scherokman; R H Whitham
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

10.  Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

Authors:  A Paolillo; A J Coles; P D Molyneux; M Gawne-Cain; D MacManus; G J Barker; D A Compston; D H Miller
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

View more
  3 in total

1.  The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis.

Authors:  Shahla Najafi Doulatabad; Khirollah Nooreyan; Ardavan Najafi Doulatabad; Zinat Mohebbi Noubandegani
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

2.  Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial.

Authors:  Fereshteh Ashtari; Mohammad Reza Savoj
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

3.  Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients.

Authors:  Sara Zarei; Irvin Maldonado; Laura Franqui-Dominguez; Cristina Rubi; Yanibel Tapia Rosa; Cristina Diaz-Marty; Guadalupe Coronado; Marimer C Rivera Nieves; Golnoush Akhlaghipour; Angel Chinea
Journal:  Surg Neurol Int       Date:  2019-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.